DIANA PISKALA: Open Payments
NPI 1316297070 · WORCESTER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,581 in 68 payments from 13 companies in 2025. Trend: 2023 $23 · 2024 $341 · 2025 $1,581
Food & beverage: $1,550Education: $31
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 22 | $430 |
| Otsuka America Pharmaceutical, Inc. | 16 | $282 |
| Vanda Pharmaceuticals Inc. | 10 | $200 |
| Dexcom, Inc. | 1 | $159 |
| E.R. Squibb & Sons, L.L.C. | 2 | $117 |
| Lundbeck LLC | 4 | $79 |
| Madrigal Pharmaceuticals | 1 | $68 |
| Alkermes, Inc. | 3 | $65 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $58 |
| ABBVIE INC. | 2 | $38 |
Products named: AUSTEDO XR, REXULTI, FANAPT, DEXCOM G7 GSS (161), COBENFY, ABILIFY MAINTENA, REZDIFFRA, ARISTADA.
Industry payments across MA — which companies pay providers there.
